Aliona Tappert

Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study

James McCarthy, Özkan Yalkinoglu, Anand Odedra et al. · The Lancet Infectious Diseases · 2021 · 81 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial

Eliézer K. N’Goran, Maurice R. Odiere, Ronald Assandé Aka et al. · The Lancet Infectious Diseases · 2023 · 33 citations

Pharmacy, Child Health, Pediatrics +14

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands

Johan L. van der Plas, Vincent P. Kuiper, Wilhelmina Bagchus et al. · The Lancet Infectious Diseases · 2023 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Comparison of POC-CCA with Kato-Katz in Diagnosing Schistosoma mansoni Infection in a Pediatric L-Praziquantel Clinical Trial

Xiaoyan Yin, Eliézer K. N’Goran, Mamadou Ouattara et al. · Frontiers in Tropical Diseases · 2021 · 10 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17